172 related articles for article (PubMed ID: 3884566)
1. Treatment of neutropenic infection: a randomized trial comparing latamoxef (moxalactam) with cephradine plus tobramycin.
Bezwoda WR; Derman DP; Perkins S; Cassel R
J Antimicrob Chemother; 1985 Feb; 15(2):239-45. PubMed ID: 3884566
[TBL] [Abstract][Full Text] [Related]
2. Empirical treatment of febrile, neutropenic patients with tobramycin and latamoxef.
Rhodes EG; Harris RI; Welch RS; Perry DJ; Brown RM; Boughton BJ
J Hosp Infect; 1987 May; 9(3):278-84. PubMed ID: 2886533
[TBL] [Abstract][Full Text] [Related]
3. Preservation of colonization resistance parameters during empiric therapy with aztreonam in the febrile neutropenic patient.
Louie TJ; Chubb H; Bow EJ; Conly JM; Harding GK; Rayner E; James M
Rev Infect Dis; 1985; 7 Suppl 4():S747-61. PubMed ID: 3909333
[TBL] [Abstract][Full Text] [Related]
4. A randomized trial comparing imipenem/cilastatine alone with latamoxef plus tobramycin in febrile neutropenic patients with lung cancer.
Matsui K; Masuda N; Takada M; Kusunoki Y; Fukuoka M
Jpn J Clin Oncol; 1991 Dec; 21(6):428-34. PubMed ID: 1805048
[TBL] [Abstract][Full Text] [Related]
5. A multicenter comparative trial of tobramycin and ticarcillin vs moxalactam and ticarcillin in febrile neutropenic patients.
Feld R; Louie TJ; Mandell L; Bow EJ; Robson HG; Chow A; Belch A; Miedzinski L; Rachlis A; Pater J
Arch Intern Med; 1985 Jun; 145(6):1083-8. PubMed ID: 3890789
[TBL] [Abstract][Full Text] [Related]
6. Cefoperazone plus piperacillin versus mezlocillin plus tobramycin as empiric therapy for febrile episodes in neutropenic patients.
Rotstein C; Cimino M; Winkey K; Cesari C; Fenner J
Am J Med; 1988 Jul; 85(1A):36-43. PubMed ID: 3041817
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy and toxicity of moxalactam and the combination of nafcillin and tobramycin in febrile granulocytopenic patients.
Alanis A; Rehm S; Weinstein AJ
Cleve Clin Q; 1983; 50(4):385-95. PubMed ID: 6365358
[No Abstract] [Full Text] [Related]
8. Ceftazidime as a single agent in the management of children with fever and neutropenia.
Morgan G; Duerden BI; Lilleyman JS
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():347-51. PubMed ID: 6352641
[TBL] [Abstract][Full Text] [Related]
9. Moxalactam versus clindamycin plus tobramycin in the treatment of obstetric and gynecologic infections.
Sweet RL; Ohm-Smith M; Landers DV; Robbie MO
Am J Obstet Gynecol; 1985 Aug; 152(7 Pt 1):808-17. PubMed ID: 3895947
[TBL] [Abstract][Full Text] [Related]
10. A randomized controlled trial of moxalactam versus clindamycin/tobramycin in the treatment of mixed anaerobic/aerobic infections.
Joshi M; Fitzpatrick BJ; Warren JW; Caplan ES; Tenney JH
Am Surg; 1986 Sep; 52(9):467-71. PubMed ID: 3530075
[TBL] [Abstract][Full Text] [Related]
11. Moxalactam versus clindamycin plus tobramycin for the treatment of puerperal infections.
Pastorek JG; Faro S; Aldridge KE; Nicaud SK
South Med J; 1987 Sep; 80(9):1116-9. PubMed ID: 3306943
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of septicemia and severe infections with a cefradine-tobramycin combination].
Gouin F; Charrel CT; Pedrant G; Morel M; Seguin F; Bourque G
Ann Anesthesiol Fr; 1976; 17(1):37-43. PubMed ID: 984519
[TBL] [Abstract][Full Text] [Related]
13. Randomized prospective study comparing moxalactam and cefoxitin with or without tobramycin for the treatment of serious surgical infections.
Tally FP; Kellum JM; Ho JL; O'Donnell TF; Barza M; Gorbach SL
Antimicrob Agents Chemother; 1986 Feb; 29(2):244-9. PubMed ID: 3717931
[TBL] [Abstract][Full Text] [Related]
14. Management of bacterial infections in severely neutropenic subjects.
Vincent PC; Fabre S; Jennis F
Med J Aust; 1977 Oct; 2(3 Pt 2 Suppl):30-3. PubMed ID: 244772
[TBL] [Abstract][Full Text] [Related]
15. Moxalactam vs tobramycin-clindamycin. A randomized trial in secondary peritonitis.
Stellato TA; Danziger LH; Hau T; Gauderer MW; Ferron JL; Gordon N
Arch Surg; 1988 Jun; 123(6):714-7. PubMed ID: 3285809
[TBL] [Abstract][Full Text] [Related]
16. Ceftazidime in the treatment of febrile immunosuppressed children.
Darbyshire PJ; Williamson PJ; Pedler SJ; Speller DC; Mott MG; Oakhill A
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():357-60. PubMed ID: 6352644
[TBL] [Abstract][Full Text] [Related]
17. A randomized study of tobramycin plus ticarcillin, tobramycin plus cephalothin and ticarcillin, or tobramycin plus mezlocillin in the treatment of infection in neutropenic patients with malignancies.
Lawson RD; Gentry LO; Bodey GP; Keating MJ; Smith TL
Am J Med Sci; 1984; 287(1):16-23. PubMed ID: 6367466
[TBL] [Abstract][Full Text] [Related]
18. Antibacterial efficacy of cefazolin and cephradine in neutropenic mice.
Kunst MW; Mattie H; van Furth R
Infection; 1979; 7(1):30-4. PubMed ID: 370021
[TBL] [Abstract][Full Text] [Related]
19. A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.
De Jongh CA; Joshi JH; Thompson BW; Newman KA; Finley RS; Moody MR; Salvatore PC; Tenney JH; Drusano GL; Schimpff SC
Am J Med; 1986 May; 80(5C):101-11. PubMed ID: 3521269
[TBL] [Abstract][Full Text] [Related]
20. Tobramycin-cephalothin treatment in leukaemic and neutropenic patients with severe infection.
Papayannis AG; Thomopoulos D; Voulgaris E; Scliros P; Gardikas C
J Antimicrob Chemother; 1977 Jul; 3(4):311-5. PubMed ID: 893240
[No Abstract] [Full Text] [Related]
[Next] [New Search]
